DY2 Stock Chart & Stats
€9.18
€0.07(0.65%)
At close: 4:00 PM EDT
€9.18
€0.07(0.65%)
Day’s Range― - ―
52-Week Range€8.09 - €12.53
Previous CloseN/A
Volume214.00
Average Volume (3M)92.00
Market Cap
€1.84B
Enterprise Value€4.20K
Total Cash (Recent Filing)€239.00M
Total Debt (Recent Filing)€2.31B
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Oct 29, 2026EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend Yield6.05%
Share Statistics
EPS (TTM)-2.74
Shares Outstanding199,353,880
10 Day Avg. Volume192
30 Day Avg. Volume92
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.70
Price to Sales (P/S)0.62
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€11.78Price Target Upside28.34% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)1.31
Revenue Forecast (FY)€3.07B
Bulls Say, Bears Say
Bulls Say
Diversified Dental PortfolioA broad portfolio across dental disciplines diversifies demand and gives Dentsply Sirona multiple ways to serve professionals and clinics. Recurring consumables, equipment, software and services can reinforce customer relationships and support revenue resilience over several quarters.
Wellspect GrowthWellspect's growth demonstrates that targeted product launches and geographic expansion can create momentum within the portfolio despite wider company pressure. Continued adoption of newer products provides a concrete avenue for mix improvement and future revenue growth.
Positive Cash GenerationPositive operating and free cash flow provide internal funding for research, commercial investment, debt service and other priorities without relying entirely on external capital. Although below earlier peaks, ongoing generation offers meaningful support during the turnaround.
Bears Say
Persistent Revenue DeclineMulti-year revenue contraction combined with a negative TTM net margin indicates that the turnaround has not yet restored durable earnings power. Continued top-line pressure can reduce operating leverage, constrain investment returns and make sustained profitability harder to achieve.
High LeverageDebt materially exceeds equity, leaving less financial flexibility while earnings remain weak. Elevated leverage can absorb cash through financing obligations, limit capacity for strategic investment and increase the consequences if revenue declines or losses persist.
Cyclical Equipment DemandExposure to capital equipment and digital technology makes part of the business dependent on clinic investment decisions rather than only recurring procedure demand. That cyclicality can create uneven revenue and earnings, especially when customers defer larger purchases.
DENTSPLY SIRONA News
DY2 FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest stock price was €8.09 and its highest was €12.53 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is €1.84B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Oct 29, 2026 which is in 47 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Aug 06, 2026. The company reported €0.446 earnings per share for the quarter, beating the consensus estimate of €0.298 by €0.147.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of €0.136 which represents an annual dividend yield of 6.05%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.27.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 199,353,880 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of €0.446 in its last earnings report, beating expectations of €0.298. Following the earnings report the stock price went down -9.642%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in DE:DY2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€11.78 (28.34% Upside)
€11.78 (28.34% Upside)
Blogger Sentiment
Neutral
DE:DY2 Sentiment 75%
Sector Average 62%
Sector Average 62%
Insider Transactions
Bought Shares
Worth €443.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.22%
12-Months-Change
Fundamentals
Return on Equity
6.05%
Trailing 12-Months
Asset Growth
-14.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
DY2 Company Deck
DY2 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflected a mixed but constructive tone: management reported near-term top-line pressures across multiple segments (notably OIS and consumables distributor headwinds in EMEA) and acknowledged tariff and geopolitical uncertainties. Offsetting these challenges were stable adjusted EBITDA and EPS, a one-time $44 million tariff refund that materially improved cash flow and EPS, continued strategic investments in sales, clinical education and R&D, expansion of dealer partnerships, and strong Wellspect performance. Management maintained full-year guidance and emphasized that improvements from the return-to-growth action plan should become more visible in Q4 and into 2027. Given balanced operational progress and strategic momentum against ongoing revenue and regional demand headwinds, the overall message is cautiously optimistic but still in turnaround mode.View all DE:DY2 earnings summariesDY2 Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
DY2 Stock 12 Month Forecast
Average Price Target
€11.78
▲(28.34% Upside)